We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Innovations Leads £22m Funding Round for PsiOxus Therapeutics

News   Jul 10, 2012

 
Innovations Leads £22m Funding Round for PsiOxus Therapeutics
 
 
Advertisement
 

RELATED ARTICLES

Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

News

UK charity LifeArc has awarded Vicore Pharma approximately £1.5 million for the ATTRACT VP01 (C21) COVID-19 study.

READ MORE

Study Explores How Ketamine Works Against Depression

News

The anesthetic drug ketamine administered in low doses, has been shown to help treat difficult-to-treat depression. A research team has now identified a key target for the drug – specific serotonin receptors in the brain.

READ MORE

Novel Radiotherapy Reduces Swallowing Difficulties in Head and Neck Cancer

News

A randomized study has found patients with head and neck cancer experienced less adverse side effects when treated with a new optimized intensity-modulated radiation therapy (IMRT) technique designed to reduce the risk of swallowing difficulties, known as dysphagia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE